Demographic, clinical and lifestyle factors associated with high-intensity statin therapy in Australia: the AusDiab study

European Journal of Clinical Pharmacology
Karen HoJenni Ilomäki

Abstract

Clinical guidelines specify who should receive high-intensity statins; however, it is unclear how high-intensity statins are used in Australia. Our objective was to determine the demographic, clinical, and lifestyle factors associated with high-intensity statin therapy in Australia. Data from the Australian Diabetes, Obesity and Lifestyle study collected in 2011-2012 were analyzed. High-, moderate-, and low-intensity statins were defined as use of statins at doses demonstrated to reduce low-density lipoprotein cholesterol levels by > 50, 30-50, and < 30%, respectively. Logistic regression was used to estimate adjusted odd ratios (ORs) and 95% confidence intervals (CIs) for factors associated with high- versus low-to-moderate-intensity statin therapy. Overall, 1108 (24%) study participants used a statin. Data on statin intensity were available for 1072 participants. The proportions of high-, moderate-, and low-intensity statin therapy were 32 (n = 341), 65 (n = 696), and 3% (n = 35), respectively. Overall, 51% of people with prior cardiovascular disease (CVD) used a high-intensity statin. In addition to prior CVD (OR = 3.34, 95% CI = 1.95-5.73), no (OR = 1.84, 95%CI 1.02-3.31) or insufficient physical activity (OR = 1.51, 95% CI...Continue Reading

References

Jul 27, 1991·BMJ : British Medical Journal·R JacksonR Beaglehole
Jan 7, 1991·The Medical Journal of Australia·A Bauman, N Owen
Dec 1, 1990·International Journal of Epidemiology·G J MillerD C Carson
Nov 1, 1993·Clinical and Experimental Hypertension : CHE·L J Beilin, I B Puddey
May 29, 1998·Circulation·P W WilsonW B Kannel
Nov 9, 2000·Addiction·G CorraoK Poikolainen
Jun 14, 2002·Diabetes Research and Clinical Practice·David W DunstanUNKNOWN Australian Diabetes, Obesity and Lifestyle Study (AusDiab)
Mar 10, 2004·The New England Journal of Medicine·Christopher P CannonUNKNOWN Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators
Nov 5, 2005·Alcoholism, Clinical and Experimental Research·Kenneth J MukamalGeoffrey H Tofler
Dec 20, 2005·Heart, Lung & Circulation·Andrew TonkinUNKNOWN Cardiac Society of Australia and New Zealand
Sep 11, 2009·Respirology : Official Journal of the Asian Pacific Society of Respirology·Timothy J KiddUNKNOWN ACPinCF INVESTIGATORS
Mar 15, 2011·European Journal of Public Health·Jenni IlomäkiMaarit Jaana Korhonen
Sep 26, 2013·European Journal of Clinical Pharmacology·D Macías Saint-GeronsF Catalá-López
Oct 10, 2013·Pharmacoepidemiology and Drug Safety·James R WarrenLouisa Jorm
Nov 19, 2013·Journal of the American College of Cardiology·Neil J StoneUNKNOWN American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Jan 29, 2014·BMJ : British Medical Journal·Shah EbrahimPeter Brindle
Oct 23, 2014·Clinical Cardiology·Kobina A WilmotLaurence Sperling
Apr 1, 1997·Addiction Biology·I B PuddeyV Rakic
Aug 2, 2016·Heart, Lung & Circulation·Derek P ChewUNKNOWN NHFA/CSANZ ACS Guideline 2016 Executive Working Group:
Feb 20, 2017·Diabetes Research and Clinical Practice·Digsu N KoyeDianna J Magliano
Mar 23, 2017·European Journal of Preventive Cardiology·Simran JohalJenni Ilomäki
Apr 7, 2017·International Journal of Stroke : Official Journal of the International Stroke Society·Yongjun WangChuanqiang Pu
Aug 16, 2017·Journal of Clinical Lipidology·Adam M Noyes, Paul D Thompson
Apr 17, 2018·Journal of Diabetes·Richard Ofori-AsensoDanny Liew

❮ Previous
Next ❯

Citations

Dec 3, 2020·Journal of Clinical Medicine·Armando Chaure-PardosIsabel Aguilar-Palacio

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass

Software Mentioned

AusDiab

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.